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Abstract
A coding variant in ADH1B (rs1229984) that leads to the replacement of Arg48 with His48 is 
common in Asian populations and reduces their risk for alcoholism, but because of very low allele 
frequencies the effects in European or African populations have been difficult to detect. We 
genotyped and analyzed this variant in three large European and African-American case-control 
studies in which alcohol dependence was defined by DSM-IV criteria, and demonstrated a strong 
protective effect of the His48 variant (odds ratio of 0.34, 95% confidence interval 0.24, 0.48) for 
alcohol dependence, with genome-wide significance (6.6 × 10−10). The hypothesized mechanism 
of action involves an increased aversive reaction to alcohol; in keeping with this hypothesis, the 
same allele is strongly associated with a lower maximum number of drinks in a 24 hour period 
(lifetime), with p = 3×10−13. We also tested the effects of this allele on the development of 
alcoholism in adolescents and young adults and demonstrated a significant protective effect. This 
variant has the strongest effect on risk for alcohol dependence of any tested in European 
populations.
Keywords
alcohol dependence; ADH1B; alcohol dehydrogenase; protective allele; genetics; association 
study
INTRODUCTION
Alcohol dehydrogenases catalyze the first step in the oxidative metabolism of ethanol 
(beverage alcohol). The Arg48His coding SNP (rs1229984) in ADH1B, encoding the β 
subunit of alcohol dehydrogenase, dramatically affects enzyme activity; enzymes with His48 
oxidize ethanol approximately 70- to 80-fold faster than those with Arg481. In East Asian 
populations, the His48 allele is common and lowers the risk for alcoholism, with an odds 
ratio of approximately 0.2 for a single allele1–4. Although it does not trigger a full flushing 
reaction, the protective mechanism is hypothesized to involve the aversive effects of 
transiently elevated acetaldehyde, conceptually similar to the protection accorded by the 
severe flushing experienced by individuals with the inactive variant of aldehyde 
dehydrogenase 2 (ALDH2)1.
Recently, a meta-analysis of published studies on different populations, using varying 
definitions of alcohol dependence, abuse or alcohol-related diseases, reported a very robust 
association with rs1229984 in Asian populations5 (47 studies, p value = 7 × 10−42). 
However, the results for alcohol dependence in European subjects were modest (19 studies, 
p value = 0.002) and African American subjects were not studied. This His48 allele has a 
low frequency in populations of European or African descent.
In contrast to the equivocal findings of rs1229984 with alcohol dependence in subjects of 
European descent, Arg48His has been strongly implicated in cancers of the upper 
aerodigestive tract, specifically esophageal cancer, with the protective influence of His48 
being most pronounced in drinkers (N=15,841 OR=0.64 (95% CI 0.59, 0.71) p = 1 × 
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10−20)6–7. No evidence of association was seen in the relatively modest African American 
population with cancer (N=1,079 OR=0.99 (95% CI 0.46, 2.13) p = 0.98).
The purpose of this study was two-fold. We examined the association of rs1229984 in three 
large case-control studies of subjects of European and African descent in which alcohol 
dependence was directly diagnosed to test whether this SNP shows protective effects on 
alcohol dependence and alcohol consumption in non-Asian samples. We then confirmed the 
protective effect of the His48 allele in an adolescent and young adult population that is in 
the critical period of risk for the development of alcohol dependence.
SUBJECTS AND METHODS
Samples for this meta-analysis were drawn from three existing studies, the Collaborative 
Study on the Genetics of Alcoholism (COGA), the Collaborative Genetic Study of Nicotine 
Dependence (COGEND), and the Family Study of Cocaine Dependence (FSCD), each of 
which is described below. For purposes of this study, all case subjects met a lifetime 
diagnosis for DSM-IV alcohol dependence8. Control subjects had at least one drink of 
alcohol, but never met dependence for DSM-IV alcohol dependence. Characteristics of adult 
subjects from COGA, COGEND and FSCD are presented in Table 1.
Collaborative Study on the Genetics of Alcoholism (COGA)
The Collaborative Study on the Genetics of Alcoholism (COGA) was initiated in 1989 with 
funding from the National Institute on Alcohol Abuse and Alcoholism (NIAAA)9–10. 
Subjects were recruited by seven sites across the United States. Alcohol dependent probands 
were systematically recruited from treatment facilities, and relatives were interviewed. 
Comparison families were drawn from the same communities. A case-control sample of 
biologically unrelated individuals was drawn from the sample11. All cases met DSM-IV 
criteria for alcohol dependence. Control subjects were defined as individuals who consumed 
alcohol, but did not meet any definition of alcohol dependence or alcohol abuse, or abuse or 
dependence on other drugs (except nicotine). For this study 1800 COGA case-control 
subjects were studied, including 1139 DSM-IV alcohol dependent cases and 661 non-
alcohol dependent controls.
Collaborative Genetic Study of Nicotine Dependence (COGEND)
The Collaborative Genetic Study of Nicotine Dependence (COGEND) was initiated in 2001 
as a three-part program project grant funded through the National Cancer Institute12. 
Nicotine dependent and non-dependent smoking subjects were recruited from communities 
in Detroit and St. Louis, using a Health Maintenance Organization in Detroit and the 
Missouri Family Registry in St. Louis maintained at Washington University for research 
purposes. Nicotine dependent subjects were current smokers with a Fagerström Test for 
Nicotine Dependence (FTND)13 score of 4 or more. Non-nicotine dependent subjects were 
individuals who smoked at least 100 cigarettes lifetime, who never had any symptoms of 
dependence (lifetime FTND=0). For this study 2666 COGEND subjects were used, 
including 612 DSM-IV alcohol dependent cases and 2054 non-alcohol dependent controls. 
This sample includes 1610 subjects who were previously examined in Sherva et al., 200914.
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Family Study of Cocaine Dependence (FSCD)
The Family Study of Cocaine Dependence (FSCD) was initiated in 2000 as a case-control 
family study of cocaine dependence funded through the National Institute on Drug Abuse15. 
Cocaine dependent individuals were systematically recruited from chemical dependency 
treatment facilities in the greater St. Louis metropolitan area. Community based comparison 
subjects with no substance dependence were recruited through the Missouri Family Registry 
and matched by age, race, gender, and residential zip code. For this study 1166 FSCD 
subjects were used, including 547 DSM-IV alcohol dependent cases and 619 non-alcohol 
dependent comparison subjects.
Adolescent and Young Adult Study as part of the Collaborative Study on the Genetics of 
Alcoholism (COGA)
The adolescent and young adults study is a sample of subjects from the COGA study who 
had at least one assessment between the years 1989–2008 when the subjects were between 
the ages of 12 and 25 years (Table 2). Subjects were recruited from families affected with 
alcoholism (either as a first- or second-degree relative) and from community-based 
comparison families. For this analysis, 2039 adolescents and young adults who ever had a 
drink of alcohol were studied. All subjects were of European descent. This sample is 
independent of the COGA case-control sample.
Phenotyping for All Studies
Alcohol related phenotypes were derived using the Semi-Structured Assessment for the 
Genetics of Alcoholism (SSAGA) designed for genetic studies of alcoholism16–18. The 
SSAGA comprehensively assesses alcohol, nicotine and drug use and has high reliability 
and validity16–18. Alcohol and drug dependence were defined using DSM-IV criteria8 and 
nicotine dependence was characterized using the Fagerström Test for Nicotine Dependence 
(FTND)13.
In the case control samples, two phenotypes were selected for study: lifetime diagnosis of 
DSM-IV alcohol dependence and maximum number of alcoholic drinks consumed in a 24-
hour period. A standard drink of alcohol was defined as a glass of wine, a bottle of beer, or a 
shot glass of hard liquor.
For the adolescent and young adult study, subjects 18 years and older were assessed with the 
SSAGA. Adolescent subjects 17 years of age or younger were assessed with the childhood 
version of the Semi-Structured Assessment for the Genetics of Alcoholism (C-SSAGA). 
DSM-IV defined alcohol dependence was the outcome under study.
Genotyping of rs1229984
DNA was extracted from blood samples or transformed lymphoblastoid cell lines.
COGA sample and FSCD sample—We used the PrimerPicker software (http://
www.kbioscience.co.uk/primer-picker/) to design the assay and followed the protocol 
described in the KASPar SNP Genotyping System manual (http://www.kbioscience.co.uk), 
with detection on the ABI 7900 HT Fast Real-Time PCR system (Applied Biosystems, 
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Foster City, California). Sixty-nine percent of samples were also genotyped using the 
Sequenom MassArray system. Samples with discrepant results (0.3%) were discarded.
COGEND sample—A large component of this study was previously genotyped at this 
variant as part of a previous genotyping project19. To complete the genotyping in the 
sample, we used Sequenom MassArray, homogenous MassEXTEND (hME) or iPLEX 
assays for genotyping, using Sequenom SpectroTYPER software v3.4 (see Wang et al., 
2009)20.
COGA adolescent and young adult sample—Rs1229984 was included in a set of 384 
SNPs genotyped using the Illumina GoldenGate custom designed platform at the Microarray 
Core of the Genome Sequencing Center at Washington University. We used the default 
algorithm in BeadStudio (Illumina; San Diego, California) to cluster genotypes.
Statistical Analysis
Each study was analyzed separately. All studies have previously undergone extensive 
genotyping, and population structure has been reviewed with Eigenstrat21. Self reported race 
of “White” and “Black” corresponded to genetically determined groups.
Because of the low minor allele frequency for rs1229984 and the small number of subjects 
homozygous for the minor allele (less than 0.5% in each study), the G/A heterozygous 
subjects and A/A homozygous subjects were collapsed into a single group for analysis and 
compared to G/G homozygous subjects.
In the adult case control sample, alcohol dependence was analyzed using logistic regression 
to estimate odds ratios for the variant rs1229984. Maximum drinks consumed in a 24-hour 
period (MaxDrinks) was examined by linear regression of the log transformed number of 
drinks. Prior to log transformation, the few extreme values of maximum drinks in 24-hours 
(greater than 100) were set at 100. Each study was examined to determine which 
characteristics predicted alcohol dependence and maximum drinks consumed in a 24-hour 
period. Age, gender, nicotine dependence and cocaine dependence were significantly 
associated with alcohol dependence and maximum drinks consumed in a 24-hour period. 
Primary analyses were adjusted for sex, age (in quartiles), and nicotine and cocaine 
dependence.
To determine the sensitivity of analyses to the inclusion of covariates, analyses were 
repeated using SNP only as a predictor variable, and then with SNP, age (quartiles) and 
gender as predictor variables. In addition, analyses including principal components adjusting 
for population structure were performed. We combined results from the three studies to 
calculate a pooled estimate and meta-analysis p value using a fixed effects model for 
subjects of European and African descent.
In the adolescent and young adult sample, survival analysis was used to examine alcohol 
dependence. Only subjects who reported having at least one drink of alcohol were included. 
A total of 302 adolescents and young adults had developed DSM-IV alcohol dependence. 
Those subjects who had not developed alcohol dependence were designated as censored.
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RESULTS AND DISCUSSION
The frequency of alcohol dependence and comorbid nicotine and cocaine dependence is 
consistent with the study design and ascertainment protocols for each study (Table 1). 
Rs1229984 is strongly associated with alcohol dependence in each dataset (Table 3). See 
Supplementary Table 1 for results for the full models. In the meta-analysis across the three 
adult studies, which included 2298 alcohol dependent cases and 3334 non-dependent 
controls, the allele encoding His48 is significantly associated with reduced risk for alcohol 
dependence, with an odds ratio of 0.34 (95% CI 0.24, 0.48) and p value = 6.6 × 10−10. The 
magnitude of effect is similar in both European American and African American 
populations. Analyses were repeated using principal components to ensure that the 
association is not an artifact of population stratification, and results are essentially 
unchanged (Supplementary Table 2). The findings are robust, not only with respect to 
ethnicity, but also with major covariates (age, sex, nicotine and cocaine dependence), as 
removing or limiting covariates did not markedly affect the results (Supplementary Tables 3 
and 4). These results are consistent with the recent meta-analysis of Asian populations (47 
studies, AG (Arg/His) and AA (His/His) versus GG (Arg/Arg), OR=0.24 (95% CI 0.19, 
0.31), p value=2 × 10−31)5.
These results are further supported by analyses of an independent sample of adolescents and 
young adults (aged 12–25 years) of European descent. Using survival analysis, the His48 
allele is associated with a 0.51 reduced hazard of developing alcohol dependence (N=2039; 
Hazard Ratio=0.51 (95% CI 0.30, 0.88) and p value = 0.015).
The His48 allele is also associated with lower alcohol consumption as measured by the 
subjects’ lifetime maximum alcohol consumption in a 24-hour period (β = −0.28 (95% CI 
−0.35, − 0.20), p value = 3.24 × 10−13) (Table 3). A similar association is seen in both 
European American and African American subjects. These findings are consistent with, but 
exceed in magnitude, those from a prior report of association between His48 and maximum 
drinks consumed in a 24-hour period22.
These results provide strong evidence that the His48 allele in β-ADH is strongly associated 
with a reduced likelihood of a lifetime diagnosis of alcohol dependence and a lower 
maximum number of drinks consumed in a 24-hour period in individuals of both European 
and African ancestry. The effect of this association is seen early in the course of illness and 
predicts the development of alcohol dependence in adolescents and young adults who are at 
the beginning of their drinking career. The direction of these effects is similar to that found 
in Asians, among whom the allele frequency is much higher.
Because rs1229984 is not on most GWAS arrays, is relatively uncommon (< 5% minor 
allele frequency) in populations of European and African descent, and the accuracy of 
imputation is poor, the association with alcohol dependence has not been detected in several 
recent genome-wide association studies11, 23–24, including studies in which these subjects 
were included in this sample11, 24. For example, this SNP was imputed from the GWAS data 
using BEAGLE25. Though over 98% of the genotyped GG samples are correctly assigned, 
Bierut et al. Page 6
Mol Psychiatry. Author manuscript; available in PMC 2012 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
only 68% of the AG heterozygote and AA homozygote genotypes are accurately imputed. 
As a result, testing this association required direct genotyping of this SNP.
Although the population attributable risk of His48 differs because of the varying allele 
frequencies, at an individual level the effect of this ADH1B variant on amount of alcohol 
consumed and on the risk of developing alcohol dependence is the same regardless of 
ancestry. This polymorphism is an exception to the generally small effect sizes associated 
with other variants that affect complex traits including alcohol dependence; rs1229984 has a 
substantial effect on risk of developing alcohol dependency, reducing it by two-thirds.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Adjusted estimate of the age at onset of alcohol dependence among N=2039 adolescent and 
young adult ever drinkers of European-American descent.
*Survival estimates from proportional hazards regression model adjusted for gender and 
age. Shaded areas represent the 95% confidence intervals for each estimate
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Table 1
Characteristics of Adult Subjects
Study*
COGA
N=1800
COGEND
N=2666
FSCD
N=1166
Sex, N (%)
 Male 971 (53.9) 1,018 (38.2) 579 (49.7)
 Female 829 (46.1) 1,648 (61.8) 587 (50.3)
Age, years
 Mean ± sd 43.1 ± 11.4 36.5 ± 5.5 37.0 ± 8.8
 Range 18.0–79.0 25.0–47.0 18.0–60.0
Race, N (%)
 European American 1353 (75.2) 1981 (74.3) 558 (47.9)
 African American 447 (24.8) 685 (25.7) 608 (52.1)
DSM-IV Alcohol Dependence
 Diagnosis, N (%) 1139 (63.3) 612 (23.0) 547 (46.9)
FTND Nicotine Dependence
 Never Smokers, N (%) 509 (30.3) 0 505 (43.3)
 Nicotine Dependent, N (%) 803 (47.9) 1407 (52.8) 445 (38.2)
 Not Nicotine Dependent, N (%) 366 (21.8) 1259 (47.2) 216 (18.5)
DSM-IV Cocaine Dependence
 Diagnosis, N (%) 481 (26.7) 219 (8.2) 551 (47.3)
rs1229984**
 AA 5 (0/5) 6 (0/6) 1 (0/1)
 AG 96 (38/58) 162 (21/141) 51 (20/31)
 GG 1699 (1101/598) 2498 (591/1907) 1114 (527/587)
*COGA: Collaborative Study on the Genetics of Alcoholism
COGEND: Collaborative Genetic Study of Nicotine Dependence
FSCD: Family Study of Cocaine Dependence
**
Total N (Case n/Control n)
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Table 2
Characteristics of Adolescent and Young Adult Sample
Adolescents and Young Adults
N=2039
Sex, N (%)
 Male 983 (48.2)
 Female 1056 (51.8)
Age at first interview, years
 Mean ± sd 15.9 ± 5.0
 Range 6–25
DSM-IV Alcohol Dependence*
 Diagnosis, N (%) 302 (14.8)
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